TY - JOUR T1 - Positive microbiology findings in non-cystic fibrosis bronchiectasis and co-morbidities JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.congress-2016.PA2558 VL - 48 IS - suppl 60 SP - PA2558 AU - Zoran Arsovski AU - Biserka Kjaeva AU - Dejan Dokic AU - Zlatica Goseva AU - Sava Pejkovska AU - Elena Janeva AU - Suzana Arbutina AU - Angela Debreslioska AU - Anita Arsovska Y1 - 2016/09/01 UR - http://erj.ersjournals.com/content/48/suppl_60/PA2558.abstract N2 - Background: Bronchiectasis are becoming a focus of the respiratory scientists in recent years.Aim of the study: To assess microbiology findings in non-cystic fibrosis bronchiectasis (non-CFB) and frequency of associated co-morbidities.Material and methods: We analyzed 172 patients with non-CFB as a primary diagnosis that were hospitalized during a period of 61 months.Results: Positive microbiology analysis was obtained in 26,74% of the patients. 14,53% of the patients had positive results on Candida albicans. The most frequent pathogen found in sputum was Pseudomonas aeruginosa (5,81%). In 3,48% Acinetobacter species was found and E. Coli and Haemophyllus influenzae were both found in 1,74 % of the patients. Other findings were Streptococcus pyogenes, Streptococcus pneumoniae, Enterobacter aerogenes, Klebsiela pneumoniae, Aspergillus niger, Aspergillus fumigatus, Stenotrophomonas maltophilia etc. In 5,23% of patients coexistence of Candida albicans with other bacterial pathogens was found. 56,66% of the non-CFB patients with positive pathogen findings had chronic respiratory insufficiency. COPD coexisted with non-CFB in 26,66% of the patients with positive pathogen microbiology findings. Co-existence of non-CFB with other co-morbid conditions were found (i.e Kartagener Syndrome, Wegener's granulomatosis, Alcoholism, Myelodysplastic Syndrome, Esophagotracheal fistula etc). Appropriate drug treatment was carried out in all patients and one patient with esophagotracheal fistula was transferred to Surgery for consecutive treatment.Conclusion: Mayor part of fungal findings represent only colonization. Management of non-CFB should consider other co-existingdiseases and patient's condition. ER -